X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
diagnosis (20) 20
human necessities (20) 20
hygiene (20) 20
identification (20) 20
medical or veterinary science (20) 20
surgery (20) 20
adult (6) 6
female (6) 6
hematology (6) 6
humans (6) 6
index medicus (6) 6
male (6) 6
middle aged (6) 6
acute myeloid-leukemia (4) 4
aged (4) 4
life sciences (4) 4
survival (4) 4
adolescent (3) 3
aged, 80 and over (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
classification (3) 3
cytarabine - administration & dosage (3) 3
lymphoma (3) 3
prognosis (3) 3
survival analysis (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
bone-marrow-transplantation (2) 2
care and treatment (2) 2
chemotherapy (2) 2
drug administration schedule (2) 2
follow-up (2) 2
hematopoietic stem cell transplantation (2) 2
high-dose cytarabine (2) 2
mantle cell lymphoma (2) 2
mds (2) 2
oncology (2) 2
randomized-trial (2) 2
risk factors (2) 2
stem cell transplantation (2) 2
stem-cell transplantation (2) 2
therapy (2) 2
transplantation (2) 2
trial (2) 2
young adult (2) 2
1st remission (1) 1
[ sdv.mhep.hem ] life sciences [q-bio]/human health and pathology/hematology (1) 1
[ sdv.mhep.mi ] life sciences [q-bio]/human health and pathology/infectious diseases (1) 1
[sdv.can]life sciences [q-bio]/cancer (1) 1
[sdv.mhep.hem]life sciences [q-bio]/human health and pathology/hematology (1) 1
[sdv.mhep.mi] life sciences [q-bio]/human health and pathology/infectious diseases (1) 1
[sdv.mhep.mi]life sciences [q-bio]/human health and pathology/infectious diseases (1) 1
abridged index medicus (1) 1
acquired immunodeficiency syndrome (1) 1
acute myelogenous leukemia (1) 1
acute myeloid leukaemia (1) 1
adults (1) 1
aids (1) 1
anti-hiv agents - therapeutic use (1) 1
antineoplastic agents - therapeutic use (1) 1
array-cgh (1) 1
array‐cgh (1) 1
asxl1 (1) 1
auer rod-like inclusions (1) 1
autografts (1) 1
b-cell (1) 1
bendamustine (1) 1
bortezomib (1) 1
cancer therapies (1) 1
cbl protein (1) 1
cd4 lymphocyte count (1) 1
cell survival (1) 1
chronic myelomonocytic leukaemia (1) 1
chronic myelomonocytic leukemia (1) 1
cisplatin - administration & dosage (1) 1
classifications (1) 1
classifications; diagnostic haematology; mds; neutropenia; thrombocytopenia; hematology (1) 1
cohort studies (1) 1
colony-stimulating factor (1) 1
combination (1) 1
combined modality therapy (1) 1
comparative genomic hybridization (1) 1
cross-sectional studies (1) 1
cross-sectional study (1) 1
cyclophosphamide - administration & dosage (1) 1
cytarabine (1) 1
daunorubicin (1) 1
daunorubicin - administration & dosage (1) 1
dexamethasone (1) 1
dexamethasone - administration & dosage (1) 1
diagnostic haematology (1) 1
disease management (1) 1
disease progression (1) 1
disease-free survival (1) 1
dna mutational analysis - methods (1) 1
dna, neoplasm - genetics (1) 1
dose cytarabine (1) 1
dose escalation (1) 1
dose-response relationship, drug (1) 1
doxorubicin (1) 1
doxorubicin - administration & dosage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 13, pp. 1250 - 1260
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2010, Volume 151, Issue 4, pp. 365 - 375
Journal Article
Haematologica, ISSN 0390-6078, 01/2019, Volume 104, Issue 1, pp. 138 - 146
We present results of a prospective, multicenter, phase II study evaluating rituximab, bendamustine, bortezomib and dexamethasone as first-line treatment for... 
MOLECULAR REMISSION | INDUCTION THERAPY | DOSE CYTARABINE | B-CELL | PLUS RITUXIMAB | RANDOMIZED-TRIAL | FOLLOW-UP | OPEN-LABEL | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | TRANSPLANTATION | Life Sciences | Immunology
Journal Article
British Journal of Haematology, ISSN 0007-1048, 12/2016, Volume 175, Issue 5, pp. 975 - 979
Journal Article
Annales de biologie clinique, 01/2018, Volume 76, Issue 1, p. 114
We report a 69-year-old adult case with a monoclonal gammopathy incidentally discovered, associated with a moderate thrombocytopenia of 90 G/L. Study of blood... 
Journal Article
Annales de Biologie Clinique, ISSN 0003-3898, 01/2018, Volume 76, Issue 1, pp. 114 - 117
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3736 - 3736
Abstract Background: The treatment of Acute Myeloid Leukemia (AML) in elderly patients remains unsatisfactory, with an expected survival time of about 1 year... 
Life Sciences
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1774 - 1774
Abstract BACKGROUND Few Tx options are available for pts with inadequately controlled PV. European LeukemiaNet defined resistance/intolerance was seen in ≈25%... 
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 07/2019, pp. 1 - 10
Ruxolitinib was recently approved for the treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea based on data from the... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 467 - 467
Abstract Background :AZA improves overall survival (OS) in higher risk MDS, but only 50-60% of the patients respond, and median OS with AZA is only 20-24... 
Journal Article
Haematologica, ISSN 0390-6078, 06/2010, Volume 95, Issue 6, pp. 892 - 899
Journal Article
Cancer, ISSN 0008-543X, 02/2004, Volume 100, Issue 4, pp. 667 - 676
BACKGROUND Optimal treatment of human immunodeficiency virus (HIV)‐associated non‐Hodgkin lymphoma (NHL) has yet to be defined, because chemotherapy could... 
dose escalation | hematology | human immunodeficiency virus–associated non‐Hodgkin lymphoma | chemotherapy | lymphoma | acquired immunodeficiency syndrome | Chemotherapy | Dose escalation | Hematology | Lymphoma | Acquired immunodeficiency syndrome | Human immunodeficiency virus-associated non-Hodgkin lymphoma | human immunodeficiency virus-associated non-Hodgkin lymphoma | SURVIVAL | BONE-MARROW-TRANSPLANTATION | DOXORUBICIN | AIDS | COMBINATION | INFUSIONAL CYCLOPHOSPHAMIDE | M-BACOD | ONCOLOGY | HIGH-DOSE THERAPY | STEM-CELL TRANSPLANTATION | STANDARD REGIMEN CHOP | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Injections, Intravenous | Prognosis | Humans | Middle Aged | Male | Lymphoma, Non-Hodgkin - radiotherapy | Viral Load | Dose-Response Relationship, Drug | Vincristine - administration & dosage | Adult | Anti-HIV Agents - therapeutic use | Female | Radiotherapy, Adjuvant | Doxorubicin - administration & dosage | Lymphoma, Non-Hodgkin - drug therapy | Prednisone - administration & dosage | Drug Administration Schedule | Lymphoma, Non-Hodgkin - virology | Treatment Outcome | CD4 Lymphocyte Count | Cytarabine - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | HIV Infections - complications | Methotrexate - administration & dosage | Infusions, Intravenous | Granulocyte Colony-Stimulating Factor - administration & dosage | Care and treatment | Oncology, Experimental | Research | Non-Hodgkin's lymphomas | HIV (Viruses) | Statistics | Risk factors
Journal Article
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 09/2018, p. JCO2018787366
Acute myeloid leukemia (AML) in elderly patients has a poor prognosis. In an attempt to improve outcome for these patients, the prospective open-label phase... 
Journal Article
Journal Article